Atika Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-47,000
| Closed | -$3.21M | – | 117 |
|
|
2021
Q1 | $3.21M | Sell |
47,000
-96,000
| -67% | -$6.56M | 0.28% | 70 |
|
|
2020
Q4 | $12.3M | Buy |
143,000
+14,500
| +11% | +$1.24M | 0.96% | 42 |
|
|
2020
Q3 | $8.35M | Sell |
128,500
-17,000
| -12% | -$1.11M | 0.68% | 45 |
|
|
2020
Q2 | $10.6M | Buy |
145,500
+71,500
| +97% | +$5.23M | 1.37% | 21 |
|
|
2020
Q1 | $2.52M | Sell |
74,000
-11,000
| -13% | -$374K | 0.48% | 53 |
|
|
2019
Q4 | $4.63M | Buy |
85,000
+9,000
| +12% | +$490K | 0.89% | 50 |
|
|
2019
Q3 | $3.17M | Sell |
76,000
-36,893
| -33% | -$1.54M | 0.67% | 46 |
|
|
2019
Q2 | $4.94M | Buy |
112,893
+41,893
| +59% | +$1.83M | 0.97% | 40 |
|
|
2019
Q1 | $3.66M | Buy |
+71,000
| New | +$3.66M | 0.74% | 42 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 102 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 101 |
|